Zobrazeno 1 - 10
of 216
pro vyhledávání: '"Wei-Ming Chi"'
Autor:
Shih-Hsin Tu, Yi-Chen Hsieh, Li-Chi Huang, Chun-Yu Lin, Kai-Wen Hsu, Wen-Shyang Hsieh, Wei-Ming Chi, Chia-Hwa Lee
Publikováno v:
BMC Cancer, Vol 17, Iss 1, Pp 1-10 (2017)
Abstract Background As cancer metastasis is the deadliest aspect of cancer, causing 90% of human deaths, evaluating the molecular mechanisms underlying this process is the major interest to those in the drug development field. Both therapeutic target
Externí odkaz:
https://doaj.org/article/d592efdb704d4703ab8eb2afa3155a1f
Autor:
Shu-Huey Chen, Jyh-Ming Chow, Yao-Yu Hsieh, Chun-Yu Lin, Kai-Wen Hsu, Wen-Shyang Hsieh, Wei-Ming Chi, Beished M. Shabangu, Chia-Hwa Lee
Publikováno v:
International Journal of Molecular Sciences, Vol 20, Iss 9, p 2271 (2019)
Since imatinib (Glivec or Gleevec) has been used to target the BCR-ABL fusion protein, chronic myeloid leukemia (CML) has become a manageable chronic disease with long-term survival. However, 15%−20% of CML patients ultimately develop resistance to
Externí odkaz:
https://doaj.org/article/35b9e66b565f418aabada5b532a51945
Autor:
Ching-Ling Lin, Ming-Lin Tsai, Chun-Yu Lin, Kai-Wen Hsu, Wen-Shyang Hsieh, Wei-Ming Chi, Li-Chi Huang, Chia-Hwa Lee
Publikováno v:
International Journal of Molecular Sciences, Vol 20, Iss 2, p 454 (2019)
Anaplastic thyroid carcinoma (ATC) and squamous thyroid carcinoma (STC) are both rare and advanced thyroid malignancies with a very poor prognosis and an average median survival time of 5 months and less than 20% of affected patients are alive 1 year
Externí odkaz:
https://doaj.org/article/48f5fd3a5b3c46ce91edac1fa6f88f99
Autor:
Kai-Wen Hsu, Chien-Yu Huang, Ka-Wai Tam, Chun-Yu Lin, Li-Chi Huang, Ching-Ling Lin, Wen-Shyang Hsieh, Wei-Ming Chi, Yu-Jia Chang, Po-Li Wei, Shou-Tung Chen, Chia-Hwa Lee
Publikováno v:
International Journal of Molecular Sciences, Vol 19, Iss 2, p 452 (2018)
Breast cancer is the most common malignancy in women and the second leading cause of cancer death in women. Triple negative breast cancer (TNBC) subtype is a breast cancer subset without ER (estrogen receptor), PR (progesterone receptor) and HER2 (hu
Externí odkaz:
https://doaj.org/article/60868144dc7c48ebbd07f7114db801cf
Autor:
Wei, Ming-Chi, Lee, Wen-Lung, Huang, Pao-Hui, Wei, Da-Hsiang, Jheng, Zun-Siao, Yang, Yu-Chiao
Publikováno v:
In Food and Bioproducts Processing May 2024 145:239-249
Publikováno v:
In Food Chemistry 1 February 2022 369
Publikováno v:
In Microchemical Journal June 2021 165
Publikováno v:
In Food and Bioproducts Processing November 2019 118:77-90
Publikováno v:
In Journal of CO2 Utilization July 2019 32:219-231
Autor:
Yang, Yu-Chiao, Wei, Ming-Chi
Publikováno v:
In Food Chemistry 30 June 2018 252:381-389